— Professor George Hanna, Director, NIHR Diagnostic Evidence Co-operative and Head of Surgery, St. Mary’s Hospital, Paddington, London
“Ingenza’s simple diagnostic assay for confirming nasogastric (NG) tube placement is an easy-to-implement and low cost option, providing a highly specific and sensitive test with the potential to reduce the number of expensive chest X-rays.”
Ingenza’s development process
Discovery & Optimisation
Ingenza is a world class engineering biology company, providing rapid, efficient and cost effective methods including proprietary gene assembly, optimised recombinant production in microbial or mammalian hosts, and high throughput screening assays for your novel drug target.
Ingenza’s 13,500 sq ft facility in Edinburgh, Scotland fully integrates molecular biology, scalable fermentation, and a full analytical chemistry suite to deliver solutions for our biopharmaceutical customers.